Miki, Hirokazu <br/><br/>
Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma.  [electronic resource] 

 -  International journal of hematology  Mar 2009 
 - 223-226 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1865-3774 
<br/><br/><label>Standard No.: </label>10.1007/s12185-009-0255-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies<br/>Boronic Acids--therapeutic use<br/>Bortezomib<br/>Dexamethasone--therapeutic use<br/>Female<br/>HLA Antigens--immunology<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Platelet Transfusion<br/>Pyrazines--therapeutic use<br/>Salvage Therapy<br/>Transplantation, Homologous